Literature DB >> 6364075

Metabolic epidemiology of prostatic cancer.

E L Wynder, K Laakso, M Sotarauta, D P Rose.   

Abstract

A review of the epidemiological evidence indicates that dietary fat very likely has an etiologic role in the development of prostatic carcinoma. While this effect may be mediated by way of altered hormonal action on the prostate, there is little supporting evidence from assays of plasma or urinary hormones in case-control studies or the investigation of high-risk and low-risk groups. The application of metabolic epidemiology to this problem is most likely to succeed by direct studies of the prostate gland, and the performance of relevant assays on prostatic fluid. Estradiol and estrone levels were found to be higher in prostatic fluid than in serum, whereas for prolactin the reverse was true. Testosterone concentrations were very low in prostatic fluid, perhaps because of the high degree of plasma protein binding. Preliminary data indicated that prostatic fluid estradiol and prolactin levels are elevated in some prostate cancer patients; estrone levels appear to be normal.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6364075     DOI: 10.1002/pros.2990050105

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  6 in total

1.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

2.  Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer.

Authors:  S Vijayakumar; S F Quadri; L Dong; L Ignacio; I N Kathuria; H Sutton; H Halpern
Journal:  J Natl Med Assoc       Date:  1995-11       Impact factor: 1.798

3.  Current status of prostate cancer in North American black males.

Authors:  C Mebane; T Gibbs; J Horm
Journal:  J Natl Med Assoc       Date:  1990-11       Impact factor: 1.798

4.  Words of wisdom. Re: Testosterone treatment is a potent tumor promoter for the rat prostate.

Authors:  Jason M Scovell; Peter Butler; Ranjith Ramasamy; Dolores J Lamb
Journal:  Eur Urol       Date:  2015-04       Impact factor: 20.096

Review 5.  Exercise and prostate cancer.

Authors:  Dorothea C Torti; Gordon O Matheson
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 6.  Canine prostate models in preclinical studies of minimally invasive interventions: part I, canine prostate anatomy and prostate cancer models.

Authors:  Fei Sun; Claudia Báez-Díaz; Francisco Miguel Sánchez-Margallo
Journal:  Transl Androl Urol       Date:  2017-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.